According to SEC filings for the period ending December 2025, Alto Neuroscience, Inc. (NYSE:ANRO) is held by 94 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Alpha Wave Global, LP | 31 Dec, 2025 | 3,707,757 | 0 | 0.00% | $65,998,075.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 2,485,000 | 1,535,000 | 161.58% | $44,233,000.00 |
| Commodore Capital LP | 31 Dec, 2025 | 1,823,196 | 1,823,196 | 0.00% | $32,452,889.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 1,784,393 | 1,629,027 | 1,048.51% | $31,762,195.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 1,606,954 | 274,517 | 20.60% | $28,603,781.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 1,536,000 | -100,000 | -6.11% | $27,340,800.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,365,847 | 260,440 | 23.56% | $24,312,077.00 |
| FRANKLIN RESOURCES INC | 31 Dec, 2025 | 1,119,578 | -43,030 | -3.70% | $19,928,488.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 1,035,551 | 1,035,551 | 0.00% | $18,432,808.00 |
| 72 Investment Holdings, LLC | 31 Dec, 2025 | 667,778 | 0 | 0.00% | $11,886,448.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 629,985 | 314,227 | 99.52% | $11,213,733.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 607,874 | 239,995 | 65.24% | $10,820,158.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 477,101 | 0 | 0.00% | $8,492,398.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 474,373 | 13,088 | 2.84% | $8,443,839.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 375,000 | -25,000 | -6.25% | $6,675,000.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 336,762 | 336,762 | 0.00% | $5,994,364.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 287,435 | 49,535 | 20.82% | $5,118,477.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 253,992 | -27,971 | -9.92% | $4,521,058.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 241,741 | 193,375 | 399.82% | $4,302,989.00 |
| AWM Investment Company, Inc. | 31 Dec, 2025 | 225,000 | -55,483 | -19.78% | $4,005,000.00 |